Tenet stock dips following Jefferies downgrade

Jefferies downgraded Tenet’s stock from buy to hold, saying any sale of its revenue-cycle management subsidiary isn’t likely to net more than $2.5 billion.

Read the full post on Modern Healthcare Breaking News